Search results
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 6 hours agoSales of AstraZeneca's biggest cancer treatment, Tagrisso, leapt 12% to nearly $1.6 billion. The...